Hepatitis B and C Public Policy Association asbl
In April 2009 a group of leading European scientists, professors, public health experts and patient advocates created the Hepatitis B and C Summit Conferences Association as a Luxembourg-based not-for-profit Association (association sans but lucratif). The Association aimed primarily to deliver a summit conference on Hepatitis B and C in Europe, which was held in Brussels in October 2010 under the auspices of the Belgian EU Presidency.
The Association acknowledges with grateful thanks the support of the European Association for the Study of the Liver (EASL), the European Centre for Disease Prevention and Control (ECDC), the European Commission’s Directorate-General for Health and Consumers (DG SANCO), the European Monitoring Centre for Drugs and Drug Addiction (EMDCCA), the European Liver Patients Association (ELPA), the Viral Hepatitis Prevention Board (VHPB), the World Health Organisation – Europe (WHO-Europe) and the World Hepatitis Alliance (WHA) in its past activities.
Hepatitis B&C Public Policy Association is a founding member of the ACHIEVE coalition (Associations Collaborating on Hepatitis to Immunize and Eliminate the Viruses in Europe) which calls on the EU to take action to eliminate hepatitis B and C in Europe by 2030.
The Association’s work in the field of viral hepatitis B and C will continue to be developed in collaboration with the stakeholders mentioned above.
In June 2011 the Association’s name was changed to Hepatitis B and C Public Policy Association to reflect the broader, continuing activities of the Association.
Financial contributions received in support of the Association’s activities are made directly to the Association’s Luxembourg bank account, and are disbursed at the discretion of its Directors. The current Sponsors of Hepatitis B&C Public Policy Association are: Gilead Sciences, AbbVie and MSD.
The auditors to the Association are Grant Thornton Audit & Assurance, 13B, rue de Bitbourg L- 1273 Luxembourg.
The Directors and members of the Association ensure and uphold its independence from its sponsors and other external partners.
Meet The Directors & Members of the Association
Professor of Epidemiology and Preventive Medicine Head, National Retrovirus Reference Centre Director, Department of Hygiene, Epidemiology & Medical Statistics Athens University Medical School, Greece
Professor and Chairman, Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School (MHH)
Director, Centre for Individualised Infection Medicine (CIIM), Hannover
Clinical Director, Helmholtz Centre for Infection Research (HZI), Braunschweig, Germany
National and Kapodistrian University of Athens Medical School, Greece
Liver Unit, Department of Internal Medicine, Vall d’Hebron University Hospital, Barcelona, Spain
Executive Director, International Centre for Migration and Health (ICMH), Geneva, Switzerland
Department of Hepatology Hôpital Beaujon, AP-HP INSERM U773, University of Paris-VII, Clichy, France
Head, Liver Center for Translational Research, IRCCS Humanitas, Milan, Italy
Chairman of the EASL International Liver Foundation, Geneva, Switzerland.
Director, Gastroenterology and Internal Medicine University of Palermo, Italy
Professor of Hepatogastroenterology & Infectious Diseases Past Vice President of Cairo University, Egypt Egyptian Nile Award in Science 2016 State Merit Award in Medical Science 2010 WHO STAC Member Past President of International Association for Study of Liver Diseases
Chair, Hellenic Patients Association “Prometheus”, Athens, Greece.
Associate Professor, University of Barcelona
Associate Researcher, ISGlobal, Hospital Clínic, University of Barcelona
Member of Portuguese Parliament – Head of Public Health – Medical Doctor – University Professor -Public Health Advocate
Health Protection Scotland Centre for Virus Research Glasgow, Scotland
Executive Director of The Medicines Patent Pool (MPP) Governance Board, Geneva, Switzerland.
Head, UHN Liver Clinic, Toronto Western Hospital, Canada
Service d’Hépatologie, Hôpital Beaujon, APHP University of Paris, France
President, World Hepatitis Alliance
Professor of Medicine Chair, Dept. of Internal Medicine and Gastroenterology (IMuG) Hepatology, Endocrinology, Rheumatology and Nephrology Centralized Emergency Service (ZAE) Klinikum Klagenfurt am Wörthersee Klagenfurt, Austria
Professor Emeritus, Hepatology and Gastroenterology, Imperial College, London, UK.
Professor of Hepatology Imperial College, London, UK
Vice Rector, Acibadem University Acibadem Kozyatagi Hospital Dept of Gastroenterology Istanbul, Turkey.
Viral Hepatitis Prevention Board (VHPB) Vaccine and Infectious Disease Institute, Antwerp, Belgium
Professor and Chairman, Department of Gastroenterology and Hepatology at the University Clinic Essen, Essen, Germany